spacer
spacer

PDBsum entry 2rdl

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Hydrolase/hydrolase inhibitor PDB id
2rdl

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
226 a.a. *
Ligands
MSU-ALA-ALA-PRO-
ALV-0QE
×2
SO4 ×4
Waters ×127
* Residue conservation analysis
PDB id:
2rdl
Name: Hydrolase/hydrolase inhibitor
Title: Hamster chymase 2
Structure: Chymase 2. Chain: a, b. Engineered: yes. Methoxysuccinyl-ala-ala-pro-ala-chloromethylketone inhibitor. Chain: i, j. Engineered: yes
Source: Mesocricetus auratus. Golden hamster. Organism_taxid: 10036. Expressed in: unidentified baculovirus. Expression_system_taxid: 10469. Synthetic: yes
Resolution:
2.50Å     R-factor:   0.186     R-free:   0.253
Authors: J.Spurlino,M.Abad,J.Kervinen
Key ref:
J.Kervinen et al. (2008). Structural basis for elastolytic substrate specificity in rodent alpha-chymases. J Biol Chem, 283, 427-436. PubMed id: 17981788 DOI: 10.1074/jbc.M707157200
Date:
24-Sep-07     Release date:   30-Oct-07    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
O70164  (O70164_MESAU) -  Chymase 2 from Mesocricetus auratus
Seq:
Struc:
247 a.a.
226 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 

 
DOI no: 10.1074/jbc.M707157200 J Biol Chem 283:427-436 (2008)
PubMed id: 17981788  
 
 
Structural basis for elastolytic substrate specificity in rodent alpha-chymases.
J.Kervinen, M.Abad, C.Crysler, M.Kolpak, A.D.Mahan, J.A.Masucci, S.Bayoumy, M.D.Cummings, X.Yao, M.Olson, L.de Garavilla, L.Kuo, I.Deckman, J.Spurlino.
 
  ABSTRACT  
 
Divergence of substrate specificity within the context of a common structural framework represents an important mechanism by which new enzyme activity naturally evolves. We present enzymological and x-ray structural data for hamster chymase-2 (HAM2) that provides a detailed explanation for the unusual hydrolytic specificity of this rodent alpha-chymase. In enzymatic characterization, hamster chymase-1 (HAM1) showed typical chymase proteolytic activity. In contrast, HAM2 exhibited atypical substrate specificity, cleaving on the carboxyl side of the P1 substrate residues Ala and Val, characteristic of elastolytic rather than chymotryptic specificity. The 2.5-A resolution crystal structure of HAM2 complexed to the peptidyl inhibitor MeOSuc-Ala-Ala-Pro-Ala-chloromethylketone revealed a narrow and shallow S1 substrate binding pocket that accommodated only a small hydrophobic residue (e.g. Ala or Val). The different substrate specificities of HAM2 and HAM1 are explained by changes in four S1 substrate site residues (positions 189, 190, 216, and 226). Of these, Asn(189), Val(190), and Val(216) form an easily identifiable triplet in all known rodent alpha-chymases that can be used to predict elastolytic specificity for novel chymase-like sequences. Phylogenetic comparison defines guinea pig and rabbit chymases as the closest orthologs to rodent alpha-chymases.
 
  Selected figure(s)  
 
Figure 4.
FIGURE 4. Structural analysis of the catalytic cleft. A, accessible surface of molecules A (white-blue-red) and B (green-blue-red) in the asymmetric unit with MeOSuc-Ala-Ala-Pro-Ala-CMK shown for molecule A. B, semitransparent surface representation of the catalytic cleft of HAM2. The stick model in color-by-atom denotes MeOSuc-Ala-Ala-Pro-Ala-CMK bound to HAM2. Suc-Ala-Ala-Pro-Phe-CMK (magenta), covalently bound to the crystal structure of human chymase (37), is superimposed onto the HAM2 structure. Molecular figures were prepared with PyMOL (DeLano Scientific LLC, www.pymol.org).
Figure 5.
FIGURE 5. Schematic diagram of the hydrogen bond and other interactions between HAM2 and the inhibitor MeOSuc-Ala-Ala-Pro-Ala-CMK.
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (2008, 283, 427-436) copyright 2008.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20335663 C.C.Wei, N.Hase, Y.Inoue, E.W.Bradley, E.Yahiro, M.Li, N.Naqvi, P.C.Powell, K.Shi, Y.Takahashi, K.Saku, H.Urata, L.J.Dell'italia, and A.Husain (2010).
Mast cell chymase limits the cardiac efficacy of Ang I-converting enzyme inhibitor therapy in rodents.
  J Clin Invest, 120, 1229-1239.  
19073880 M.K.Andersson, M.Enoksson, M.Gallwitz, and L.Hellman (2009).
The extended substrate specificity of the human mast cell chymase reveals a serine protease with well-defined substrate recognition profile.
  Int Immunol, 21, 95.  
18353771 G.H.Caughey, J.Beauchamp, D.Schlatter, W.W.Raymond, N.N.Trivedi, D.Banner, H.Mauser, and J.Fingerle (2008).
Guinea pig chymase is leucine-specific: a novel example of functional plasticity in the chymase/granzyme family of serine peptidases.
  J Biol Chem, 283, 13943-13951.  
18713008 S.M.Belkowski, J.Masucci, A.Mahan, J.Kervinen, M.Olson, L.de Garavilla, and M.R.D'Andrea (2008).
Cleaved SLPI, a novel biomarker of chymase activity.
  Biol Chem, 389, 1219-1224.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time.

 

spacer

spacer